Impact of soy‐based versus composite lipid emulsion (soybean, medium chain triglycerides, olive and fish oil) in critically ill patients
Conference Proceeding - Restricted Access
Journal of Parenteral and Enteral Nutrition ( JPEN )
Background: Parenteral composite lipid emulsion has been shown to provide an anti‐inflammatory effect. Recent meta‐analysis demonstrated a reduced hospital and intensive care unit lengths of stay (LOS) and reduced rates of infections with composite lipid emulsion. The study site used parenteral soy‐based lipids in critically ill patients prior to 2017 and composite lipids were used based on criteria‐based. In 2020, composite lipids were approved for use in all critically ill patients at the study site. This study evaluated the impact of soy‐based versus composite lipid emulsion on clinical outcomes of combined infections and liver dysfunction.
Kless S, Zimmernan LH, Kroneman O. Impact of soy‐based versus composite lipid emulsion (soybean, medium chain triglycerides, olive and fish oil) in critically ill patients. Journal of Parenteral and Enteral Nutrition (JPEN) 2022;46:S100-S101. doi: 10.1002/jpen.2345